Chapter 7
Functions of the Kidney:
Removal of waste, toxic, and surplus products from the body.
Maintenance of homeostasis of body water levels.
Regulation of acid-base levels and electrolytes.
Hormonal regulation.
Renal Function Tests include:
Blood Urea Nitrogen (BUN).
Creatinine levels.
Electrolytes (sodium Na, potassium K, chloride Cl).
Nonprotein nitrogen (NPN).
Nonprotein Nitrogen:
Products of protein and nucleic acid catabolism.
Contain nitrogen but are not part of a protein.
Removed from the body by the kidneys.
Major nitrogen-containing metabolic product from protein catabolism.
Factors affecting BUN levels:
Urea concentration.
Glomerular filtration rate (GFR).
Body hydration.
Clinical significance:
Uremia: Increased urea in the blood.
Azotemia: Increased levels of BUN and other NPNs—classified as prerenal, renal, or postrenal.
Decreased BUN levels may indicate different clinical issues.
BUN methodologies:
Enzymatic urease method.
Diacetyl reaction.
Waste product from the metabolism of creatine and phosphocreatine:
Reaction: Phosphocreatine + ADP → Creatine + ATP.
Reaction: Creatine → Creatinine + H2O.
Factors affecting creatinine levels:
Relative muscle mass.
Creatine turnover rate.
Renal function.
Clinical significance:
Serves as an index of renal function (GFR).
Methodologies for measuring creatinine include:
Jaffe reaction (creatinine and picric acid).
Enzymatic creatininase (creatinine amidohydrolase with creatine kinase).
Major product of nucleoprotein catabolism produced in the liver from xanthine:
Reaction: Xanthine → Uric acid.
Clinical significance:
Primary hyperuricemia: Excess uric acid in blood.
Secondary hyperuricemia.
Hypouricemia: Low uric acid levels.
Methodologies:
Phosphotungstic acid method.
Uricase and Xanthine oxidase method.
Most popular and practical method for estimating GFR:
Freely filtered by glomeruli, not significantly reabsorbed by tubules.
Released into plasma at a constant rate.
Calculation includes:
Serum creatinine level.
Urine creatinine level.
Urine volume corrected for body surface area (BSA).
Clinical significance:
Decreased CrCl indicates decreased GFR and potential renal damage.
Increased CrCl generally not clinically significant.
Formulas:
U = urine concentration (mg/dL).
P = plasma concentration (mg/dL).
V = urine flow (mL/min).
Estimation of GFR using serum creatinine levels.
Utilizes the Modification of Diet in Renal Disease (MDRD) equation based on:
Serum/plasma creatinine level.
Age.
Gender.
Race.
eGFR Calculator is available through the National Kidney Foundation.
Protein:Creatinine Ratio:
Predicts the presence of significant proteinuria.
Inulin Clearance:
Inulin injected, serum, and urine levels measured over 3 hours.
Fewer practical methodologies; requires extensive procedures including water loading and bladder catheterization.
Cystatin C:
Freely filtered by glomeruli, catabolized in the proximal convoluted tubule (PCT).
Produced at constant rate; levels affected by various factors.
Produced during the catabolism of amino acids:
Converted to urea in the liver and excreted as ammonium ion by the kidneys.
Clinical concerns:
Extremely toxic to human cells.
Elevated levels in severe liver disease, Reye’s syndrome, and inherited urea cycle enzyme deficiencies.
Methodologies for measuring ammonia:
Ion-selective electrode.
Spectrophotometric methods.
Enzymatic methods.
Special specimen handling requirements are necessary.